참고문헌
- Toda T, Kobayashi K, Konoda-Iida E, Sasaki J, Nakamura Y. The Fukuyama congenital muscular dystrophy story. Neuromuscul Disord 2000;10:153-9. https://doi.org/10.1016/S0960-8966(99)00109-1
- Fukuyama Y, Kawazura M, Haruna H. A peculiar form of congenital progressive muscular dystrophy: report of fifteen cases. Paediatr Univ Tokyo 1960;4:5-8.
- Aida N. Fukuyama congenital muscular dystrophy: a neuroradiologic review. J Magn Reson Imaging 1998;8:317-26. https://doi.org/10.1002/jmri.1880080211
- Toda T, Segawa M, Nomura Y, Nonaka I, Masuda K, Ishihara T, et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1993;5:283-6. https://doi.org/10.1038/ng1193-283
- Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394:388-92. https://doi.org/10.1038/28653
- Rahimov R, Kunkel LM. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol 2013;201:499-510. https://doi.org/10.1083/jcb.201212142
-
Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, et al. Mutations in the fukutinrelated protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin
${\alpha}2$ deficiency and abnormal glycosylation of$\alpha$ -dystroglycan. Am J Hum Genet 2001;69:1198-209. https://doi.org/10.1086/324412 - Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, et al. Mutations in the O-mannosyl transferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002;71:1033-43. https://doi.org/10.1086/342975
- van Reeuwijk J, Janssen M, van den Elzen C, Beltran-Valero de Bernabe D, Sabatelli P, Merlini L, et al. POMT2 mutations cause alpha-dystrogylcan hypoglycosylation and Walker-Warburg syndrome. J Med Genet 2005;42:907-12. https://doi.org/10.1136/jmg.2005.031963
- Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001;1:717-24. https://doi.org/10.1016/S1534-5807(01)00070-3
- Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alphadystroglycan. Hum Mol Genet 2003;12:2853-61. https://doi.org/10.1093/hmg/ddg307
- Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 2011;21:278-85. https://doi.org/10.1016/j.gde.2011.02.001
- Kitamura Y, Kondo E, Urano M, Aoki R, Saito K. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders. J Hum Genet 2016;61:931-42. https://doi.org/10.1038/jhg.2016.79
- Watanabe M, Kobayashi K, Jin F, Park KS, Yamada T, Tokunaga K, et al. Founder SVA retrotransposal insertion in Fukuyama-type congenital muscular dystrophy and its origin in Japanese and Northeast Asia populations. Am J Med Genet A 2005;138:344-8.
- Lee J, Lee BL, Lee M, Kim JH, Kim JW, Ki CS. Clinical and genetic analysis of a Korean patient with Fukuyama congenital muscular dystrophy. J Neurol Sci 2009;281:122-4. https://doi.org/10.1016/j.jns.2009.02.373
- Lim BC, Ki CS, Kim JW, Cho A, Kim MJ, Hwang H, et al. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. Neuromuscul Disord 2010;20:524-30. https://doi.org/10.1016/j.nmd.2010.06.005
- Cormand B, Pihko H, Bayes M, Valanne L, Santavuori P, Talim B, et al. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eyebrain disease. Neurology 2001;56:1059-69. https://doi.org/10.1212/WNL.56.8.1059
- Vogel H, Zamecnik J. Diagnostic immunohistology of muscle disease. J Neuropathol Exp Neurol 2005;64:181-93. https://doi.org/10.1093/jnen/64.3.181
-
Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, et al. Selective deficiency of
$\alpha$ -dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 2001;57:115-121. https://doi.org/10.1212/WNL.57.1.115 - Lim BC, Lee S, Shin JY, Hwang H, Kim KJ, Hwang YS, et al. Molecular diagnosis of congenital muscular dystrophies with defective glycosylation of alpha-dystroglycan using next-generation sequencing technology. Neuromuscul Disord 2013;23:337-44. https://doi.org/10.1016/j.nmd.2013.01.007
- Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, et al. Refining genotype-phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007;130:2725-35. https://doi.org/10.1093/brain/awm212
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-23. https://doi.org/10.1038/gim.2015.30
- Aida N, Tamagawa K, Takada K, Yagishita A, Kobayashi N, Chikumaru K, et al. Brain MR in Fukuyama congenital muscular dystrophy. Brain 2007;17:605-13.